SIMCERE PHARMAC. GRP LTD

The current price of S2P is 0.615 EUR — it has increased by 0.82% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SIMCERE PHARMAC. GRP LTD stocks are traded under the ticker S2P.

SIMCERE PHARMAC. GRP LTD is going to release the next earnings report on Aug 20, 2024. Keep track of upcoming events with our Earnings Calendar.

S2P stock is 0.81% volatile and has beta coefficient of 0.82. Check out the list of the most volatile stocks — is SIMCERE PHARMAC. GRP LTD there?

Yes, you can track SIMCERE PHARMAC. GRP LTD financials in yearly and quarterly reports right on TradingView.

S2P stock hasn't changed in a week, the month change is a 0.81% fall, over the last year SIMCERE PHARMAC. GRP LTD has showed a 42.52% decrease.

S2P net income for the last quarter is ‪−195.48 M‬ EUR, while the quarter before that showed ‪300.87 M‬ EUR of net income which accounts for −164.97% change. Track more SIMCERE PHARMAC. GRP LTD financial stats to get the full picture.

Yes, S2P dividends are paid annually. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (TTM)% is 3.32%. Tracking SIMCERE PHARMAC. GRP LTD dividends might help you take more informed decisions.

SIMCERE PHARMAC. GRP LTD dividend yield was 2.57% in 2023, and payout ratio reached 57.08%. The year before the numbers were 1.51% and 42.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, S2P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIMCERE PHARMAC. GRP LTD stock right from TradingView charts — choose your broker and connect to your account.

S2P reached its all-time high on Jan 13, 2023 with the price of 1.560 EUR, and its all-time low was 0.575 EUR and was reached on Mar 7, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 27, 2024, the company has ‪7.03 K‬ employees. See our rating of the largest employees — is SIMCERE PHARMAC. GRP LTD on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SIMCERE PHARMAC. GRP LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SIMCERE PHARMAC. GRP LTD stock shows the sell signal. See more of SIMCERE PHARMAC. GRP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on SIMCERE PHARMAC. GRP LTD future price: according to them, S2P price has a max estimate of 1.37 EUR and a min estimate of 0.92 EUR. Read a more detailed SIMCERE PHARMAC. GRP LTD forecast: see what analysts think of SIMCERE PHARMAC. GRP LTD and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIMCERE PHARMAC. GRP LTD EBITDA is ‪109.60 M‬ EUR, and current EBITDA margin is 12.93%. See more stats in SIMCERE PHARMAC. GRP LTD financial statements.